Description

Pharmacological validation data supporting the structural observations, including binding affinity measurements for transport inhibitors.

Figure 18

Chart

Source Paper

Structure of the human dopamine transporter and mechanisms of inhibition.

Nature (2024)

PMID: 39112705

DOI: 10.1038/s41586-024-07739-9

Cite This Figure

![Figure 18: Pharmacological validation data supporting the structural observations, including binding affinity measurements for transport inhibitors.]()

> Source: Dushyant Kumar Srivastava et al. "Structure of the human dopamine transporter and mechanisms of inhibition.." *Nature*, 2024. PMID: [39112705](https://pubmed.ncbi.nlm.nih.gov/39112705/)

<figure>
  <img src="" alt="Pharmacological validation data supporting the structural observations, including binding affinity measurements for transport inhibitors." />
  <figcaption>Figure 18. Pharmacological validation data supporting the structural observations, including binding affinity measurements for transport inhibitors.<br>  Source: Dushyant Kumar Srivastava et al. "Structure of the human dopamine transporter and mechanisms of inhibition.." <em>Nature</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39112705/">39112705</a></figcaption>
</figure>

Preuves associées

Zinc pour Neurotransmitter Imbalance

Note C · 8 études